January 14, 2026

Empowering Research Leadership: Development of an Intensive Course to Support Oncology Advanced Practitioner Participation in Clinical Trials

HonorHealth's innovative training program enhances oncology advanced practitioners' roles in clinical trials, preparing them for leadership in cancer research.

JADPRO

January 14, 2026

Two Heads Are Better Than One: Second Opinions and Collaborations in Oncology

Collaboration and second opinions proved vital in diagnosing a complex case of AL amyloidosis, showcasing the importance of teamwork in patient care.

JADPRO

January 09, 2026

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

Uncover how understanding Duffy-null associated neutrophil count can prevent unnecessary therapy interruptions in cancer treatment for patients of African descent.

JADPRO

January 09, 2026

Clinical Posters From JADPRO Live 2025

Explore how a structured Advanced Practice Provider initiative is transforming patient care in oncology through clinical decision pathways, improving outcomes, and empowering a multidisciplinary approach.

JADPRO

January 09, 2026

Flipped Nivolumab/Ipilimumab Dosing Improves Responses, Survival, and Safety in Advanced Melanoma

The flipped dose for nivolumab 3 mg/kg and ipilimumab 1 mg/kg led to improved response rates and survival findings as well as lower severe immune-related toxicities compared with the standard dose of ...

The ASCO Post

January 09, 2026

Integrative Oncology Models of Care: Practice Patterns From NCCN Member Institutions

Integrative oncology is gaining traction as patients increasingly seek complementary therapies to enhance their cancer care and quality of life.

JADPRO

January 08, 2026

Cancer Treatment: When Should Doctors Change Course?

A Keck Medicine of USC hematologist-oncologist discusses signs that a different line of cancer treatment is needed.

Keck Medicine of USC

January 08, 2026

Non–Total Body Irradiation Conditioning Regimen for Young Patients With MRD-Negative B-ALL

Using a chemotherapy-based conditioning regimen led to 2-year event-free survival rates comparable to that of total body irradiation–based conditioning regimens in pediatric and young adult patients w...

The ASCO Post

January 07, 2026

Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction

Investigators have developed and tested a hybrid reading strategy for screening mammography images with artificial intelligence (AI) that includes reads from radiologists and a stand-alone AI interpre...

The ASCO Post